Relationship between left ventricular diastolic function and atrial natriuretic factor in never-treated mild hypertensives

American Journal of Hypertension

Volumn 10, Issue 8, 1997, Pages 946-950

  Grandi, Anna Maria ^a,c   Zanzi, Paolo ^a   Ceriani, Luca ^b   Gaudio, Giovanni ^a   Bertolini, Andrea ^a   Giovanella, Luca ^b   Guasti, Luigina ^a   Roncari, Giuseppina ^b   Venco, Achille ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c NONE   (Italy)

Author keywords

Atrial natriuretic factor; Diastolic function; Essential hypertension; Myocardial hypertrophy

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; HEART AFTERLOAD; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MALE; MUSCLE STRETCHING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ATRIAL NATRIURETIC FACTOR; ECHOCARDIOGRAPHY; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; REGRESSION ANALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0030880916     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00124-6     Document Type: Article

References (31)

1. Burnett JC, Jr., Granger JP, Opgenorth TJ: Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984;247:F863-866.
2. Laragh JH: Atrial natriuretic hormone, the renin-aldosterone axis and blood pressure-electrolyte homeostasis. N Engl J Med 1985;313:1330-1340.
3. Bruun NE: On the role of atrial natriuretic factor in normotensive and hypertensive man. Danish Med Bull 1993;40:582-600.
4. Richards AM: The natriuretic peptides and hypertension. J Int Med 1994;235:543-560.
5. Sugawara A, Nakao K, Sakamoto M, et al: Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet 1985;ii:1426-1427.
6. Sagnella GA, Markandu ND, Shore AC, MacGregor GA: Raised circulating levels of atrial natriuretic peptide in essential hypertension. Lancet 1986;i:179-181.
7. MacGregor GA, Sagnella GA, Markandu ND, et al: Raised plasma levels of atrial natriuretic peptide in subjects with untreated essential hypertension. J Hypertens 1986;4(suppl 6):S567-S569.
8. Montorsi P, Tonolo G, Polonia J, et al: Correlates of plasma natriuretic factor in health and hypertension. Hypertension 1987;10:570-576.
9. Wambach G, Gotz S, Suckau G, Kaufmann W: Plasma levels of atrial natriuretic peptide are raised in essential hypertension during low and high sodium intake. Klin Wochenschr 1987;65:232-237.
10. Zachariah PK, Burnett JC, Jr., Ritter SG, et al: Atrial natriuretic peptide in human essential hypertension. Mayo Clin Proc 1987;62:782-786.
11. Nilsson P, Lindholm L, Schersten B, et al: Atrial natriuretic peptide and blood pressure in a geographically defined population. Lancet 1987;ii:883-885.
12. Larochelle P, Cusson JR, Gutkowska J, et al: Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br Med J 1987;294:1249-1252.
13. Hollister AS, Inagami T: Atrial natriuretic factor and hypertension. A review and metaanalysis. Am J Hypertens 1991;4:850-865.
14. Richards AM, Tonolo G, Tillman D, et al: Plasma atrial natriuretic peptide in stable and accelerated essential hypertension. J Hypertens 1986;4:790-791.
15. Kohno M, Yasanuri K, Matsura T, et al: Circulating atrial natriuretic polypeptyde in essential hypertension. Am Heart J 1987;113:1160-1163.
16. Ganau A, Devereux RB, Atlas SA, et al: Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics. J Am Coll Cardiol 1989;14:715-724.
17. Flickinger AL, Burnett JC, Jr., Turner ST: Atrial natriuretic peptide and blood pressure in a population-based sample. Mayo Clin Proc 1995;70:1015-1017.
18. Brooks SE, Zimmerman RS, Schwab TR, et al: Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988;62:191-195.
19. Dessì-Fulgheri P, Palermo M, Di Noto G, et al: Plasma levels of atrial natriuretic factor in mild to moderate hypertensives without signs of left ventricular hypertrophy: correlation with the known duration of hypertension. J Hum Hypertens 1988;2:177-182.
20. Wambach G, Bonner G, Stimpel M, Kaufmann W: Relationship between plasma atrial natriuretic peptide and left atrial and ventricular involvement in essential hypertension. J Hypertens 1988;6:573-577.
21. Dessì-Fulgheri P, Palermo R, Di Noto G, et al: High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Hypertens 1992; 10:161-165.
22. Pontremoli R, Bezante GP, Robaudo C, et al: Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension. Eur Heart J 1993;14:910-914.
23. Lucarini AR, Favilla S, Marini C, et al: Atrial natriuretic factor in essential hypertension: echocardiographic and humoral correlates. Clin Cardiol 1992;15:353-356.
24. Upton MT, Gibson DG: The study of left ventricular function from digitised echocardiograms. Prog Cardiovasc Dis 1978;20:359-384.
25. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: validation of the method. Circulation 1977;55:613-618.
26. Wilson JR, Reichek N, Hirshfeld J: Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med 1980;68:664-674.
27. Grandi AM, Venco A, Bertolini A, et al: Left ventricular function after reversal of myocardial hypertrophy in systemic hypertension and response to acute increase of afterload by cold pressor test. Am J Cardiol 1992;69: 1439-1441.
28. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
29. Erbas B, Ozdemir O, Pasaoglu I, et al: Short- and long-term effects of felodipine on circulating endothelin and atrial natriuretic peptide levels in essential hypertension. Nephron 1993;63:363-364.
30. Papadopoulos CL, Kokkas BA, Kotridis PS, et al: The effect of beta 1-blocker bisoprolol on atrial natriuretic peptide plasma levels in hypertensive patients. Int J Angiol 1995;4:165-168.
31. Lee CH, Hogan JC, Gibson DG: Diastolic disease in left ventricular hypertrophy: comparison of M mode and Doppler echocardiography for the assessment of rapid ventricular filling. Br Heart J 1991;65:194-200.